Publications by authors named "Mohammed Karim Moudden"
Article Synopsis
- Primary systemic AL amyloidosis is a rare blood disorder, and most treatment guidelines rely on limited studies.
- This research examined cases from two military hospitals, comparing the standard melphalan-dexamethasone treatment with newer therapies like bortezomib and lenalidomide.
- Findings showed no significant differences in survival rates between the two treatment groups, and the study suggests further research is needed, especially regarding the cost and accessibility of new therapies.
Acquired amegakaryocytic thrombocytopenic purpura is a very rare condition characterized by severe thrombocytopenia linked to the reduction or disappearance of megakaryocytes in the bone marrow. It may be primary idiopathic or secondary to many pathological conditions including hematologic disorders. We report the case of a 24-year-old patient admitted for haemorrhagic syndrome caused by immunological thrombocytopenic purpura.
View Article and Find Full Text PDF